Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The ‘Oxford-Kay Kendall Leukaemia Fund Graduate Scholarship’ based at the MRC WIMM, will commence in 2023.


A new DPhil scholarship has been endowed in the Division of Medical Sciences to be based at the MRC Weatherall Institute of Molecular Medicine within the Radcliffe Department of Medicine. Thanks to support from the Kay Kendall Leukaemia Fund (KKLF) and matched funding from the University of Oxford, the scholarship will support students to pursue research into leukaemia.

Available to applicants showing exceptional academic merit, the scholarship will cover course fees and a maintenance grant for the duration of the students’ study. The first Oxford-Kay Kendall Leukaemia Fund Graduate Scholar is expected to start in the academic year 2023-24.

Professor KJ Patel, Director of the MRC Weatherall Institute of Molecular Medicine, said: 'We are delighted to receive this generous support from the Kay Kendall Leukaemia Fund to endow a DPhil scholarship. KKLF’s commitment to advancing research into all areas of leukaemia will enable us to attract the very best scholars to Oxford.’

Similar stories

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.

2022 RDM Graduate Prize Winners

This year's RDM winners are Edward Jenkins, Antje Rottner, and Akshay Shah.

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing

The biotechnology company builds upon research conducted by Professor Jim Hughes and Prof. James Davies at the MRC Weatherall Institute of Molecular Medicine, and combines 3D genome technology and machine learning to decode the dark matter of the human genome.

KJ Patel appointed new Chief Scientist of CRUK

Alongside his new role at Cancer Research UK, Prof. Patel will continue as the Director of both the MRC Weatherall Institute for Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU).

Anjali Kusumbe receives the RMS Life Sciences Medal

The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.